Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 51

1.

Protein profiling of fine-needle aspirates reveals subtype-associated immune signatures and involvement of chemokines in breast cancer.

Franzén B, Alexeyenko A, Kamali-Moghaddam M, Hatschek T, Kanter L, Ramqvist T, Kierkegaard J, Masucci G, Auer G, Landegren U, Lewensohn R.

Mol Oncol. 2019 Feb;13(2):376-391. doi: 10.1002/1878-0261.12410. Epub 2019 Jan 7.

2.

Exosomal RNA-profiling of pleural effusions identifies adenocarcinoma patients through elevated miR-200 and LCN2 expression.

Hydbring P, De Petris L, Zhang Y, Brandén E, Koyi H, Novak M, Kanter L, Hååg P, Hurley J, Tadigotla V, Zhu B, Skog J, Viktorsson K, Ekman S, Lewensohn R.

Lung Cancer. 2018 Oct;124:45-52. doi: 10.1016/j.lungcan.2018.07.018. Epub 2018 Jul 27.

PMID:
30268479
3.

Silencing FLI or targeting CD13/ANPEP lead to dephosphorylation of EPHA2, a mediator of BRAF inhibitor resistance, and induce growth arrest or apoptosis in melanoma cells.

Azimi A, Tuominen R, Costa Svedman F, Caramuta S, Pernemalm M, Frostvik Stolt M, Kanter L, Kharaziha P, Lehtiö J, Hertzman Johansson C, Höiom V, Hansson J, Egyhazi Brage S.

Cell Death Dis. 2017 Aug 31;8(8):e3029. doi: 10.1038/cddis.2017.406.

4.

Modulation of leukotriene signaling inhibiting cell growth in chronic myeloid leukemia.

Yektaei-Karin E, Zovko A, Nilsson A, Näsman-Glaser B, Kanter L, Rådmark O, Wallvik J, Ekblom M, Dolinska M, Qian H, Stenke L.

Leuk Lymphoma. 2017 Aug;58(8):1903-1913. doi: 10.1080/10428194.2016.1262029. Epub 2016 Dec 8.

PMID:
27931141
5.

Ephrin B3 interacts with multiple EphA receptors and drives migration and invasion in non-small cell lung cancer.

Efazat G, Novak M, Kaminskyy VO, De Petris L, Kanter L, Juntti T, Bergman P, Zhivotovsky B, Lewensohn R, Hååg P, Viktorsson K.

Oncotarget. 2016 Sep 13;7(37):60332-60347. doi: 10.18632/oncotarget.11219.

6.

Melphalan-flufenamide is cytotoxic and potentiates treatment with chemotherapy and the Src inhibitor dasatinib in urothelial carcinoma.

Viktorsson K, Shah CH, Juntti T, Hååg P, Zielinska-Chomej K, Sierakowiak A, Holmsten K, Tu J, Spira J, Kanter L, Lewensohn R, Ullén A.

Mol Oncol. 2016 May;10(5):719-34. doi: 10.1016/j.molonc.2015.12.013. Epub 2016 Jan 2.

7.

Expression of the p53 target Wig-1 is associated with HPV status and patient survival in cervical carcinoma.

Xu LD, Muller S, Thoppe SR, Hellborg F, Kanter L, Lerner M, Zheng B, Lagercrantz SB, Grandér D, Wallin KL, Wiman KG, Larsson C, Andersson S.

PLoS One. 2014 Nov 7;9(11):e111125. doi: 10.1371/journal.pone.0111125. eCollection 2014.

8.

Vascular endothelial growth factor receptor 2, but not S100A4 or S100A6, correlates with prolonged survival in advanced urothelial carcinoma.

Shah CH, Viktorsson K, Kanter L, Sherif A, Asmundsson J, Rosenblatt R, Lewensohn R, Ullén A.

Urol Oncol. 2014 Nov;32(8):1215-24. doi: 10.1016/j.urolonc.2014.04.015. Epub 2014 May 28.

PMID:
24880461
9.

miRNA-214 is related to invasiveness of human non-small cell lung cancer and directly regulates alpha protein kinase 2 expression.

Salim H, Arvanitis A, de Petris L, Kanter L, Hååg P, Zovko A, Özata DM, Lui WO, Lundholm L, Zhivotovsky B, Lewensohn R, Viktorsson K.

Genes Chromosomes Cancer. 2013 Oct;52(10):895-911. doi: 10.1002/gcc.22085. Epub 2013 Aug 9.

PMID:
23929716
10.

Quantitative proteomics profiling of primary lung adenocarcinoma tumors reveals functional perturbations in tumor metabolism.

Pernemalm M, De Petris L, Branca RM, Forshed J, Kanter L, Soria JC, Girard P, Validire P, Pawitan Y, van den Oord J, Lazar V, Påhlman S, Lewensohn R, Lehtiö J.

J Proteome Res. 2013 Sep 6;12(9):3934-43. doi: 10.1021/pr4002096. Epub 2013 Aug 13.

11.

Retinoic acid receptor alpha is associated with tamoxifen resistance in breast cancer.

Johansson HJ, Sanchez BC, Mundt F, Forshed J, Kovacs A, Panizza E, Hultin-Rosenberg L, Lundgren B, Martens U, Máthé G, Yakhini Z, Helou K, Krawiec K, Kanter L, Hjerpe A, Stål O, Linderholm BK, Lehtiö J.

Nat Commun. 2013;4:2175. doi: 10.1038/ncomms3175.

12.

Neuroblastoma cells injected into experimental mature teratoma reveal a tropism for embryonic loose mesenchyme.

Jamil S, Cedervall J, Hultman I, Ali R, Margaryan NV, Rasmuson A, Johnsen JI, Sveinbjörnsson B, Dalianis T, Kanter L, Orrego A, Strizzi L, Hendrix MJ, Sandstedt B, Kogner P, Ahrlund-Richter L.

Int J Oncol. 2013 Sep;43(3):831-8. doi: 10.3892/ijo.2013.2014. Epub 2013 Jul 12.

PMID:
23857308
13.

Clinical activity of sorafenib in a previously treated advanced urothelial cancer patient.

Shah CH, Viktorsson K, Sherif A, Kanter L, Grybäck P, Lewensohn R, Sandström P, Nilsson S, Ullén A.

Anticancer Drugs. 2013 Jul;24(6):648-52. doi: 10.1097/CAD.0b013e328360c1c3.

PMID:
23542751
14.

Expression of LRIG1 and LRIG3 correlates with human papillomavirus status and patient survival in cervical adenocarcinoma.

Muller S, Lindquist D, Kanter L, Flores-Staino C, Henriksson R, Hedman H, Andersson S.

Int J Oncol. 2013 Jan;42(1):247-52. doi: 10.3892/ijo.2012.1702. Epub 2012 Nov 16.

PMID:
23165628
15.

Radioresistant cervical cancer shows upregulation of the NHEJ proteins DNA-PKcs, Ku70 and Ku86.

Beskow C, Skikuniene J, Holgersson A, Nilsson B, Lewensohn R, Kanter L, Viktorsson K.

Br J Cancer. 2009 Sep 1;101(5):816-21. doi: 10.1038/sj.bjc.6605201. Epub 2009 Aug 11.

16.

Use of narrow-range peptide IEF to improve detection of lung adenocarcinoma markers in plasma and pleural effusion.

Pernemalm M, De Petris L, Eriksson H, Brandén E, Koyi H, Kanter L, Lewensohn R, Lehtiö J.

Proteomics. 2009 Jul;9(13):3414-24. doi: 10.1002/pmic.200800814.

PMID:
19609957
17.

Deficient activation of Bak and Bax confers resistance to gemtuzumab ozogamicin-induced apoptotic cell death in AML.

Haag P, Viktorsson K, Lindberg ML, Kanter L, Lewensohn R, Stenke L.

Exp Hematol. 2009 Jun;37(6):755-66. doi: 10.1016/j.exphem.2009.03.002.

PMID:
19463775
18.

Species-specific in vivo engraftment of the human BL melanoma cell line results in an invasive dedifferentiated phenotype not present in xenografts.

Cedervall J, Jamil S, Prasmickaite L, Cheng Y, Eskandarpour M, Hansson J, Maelandsmo GM, Ringborg U, Gulyas M, Zhen HS, Kanter L, Ahrlund-Richter L.

Cancer Res. 2009 May 1;69(9):3746-54. doi: 10.1158/0008-5472.CAN-08-3746. Epub 2009 Apr 21.

19.

The common Scandinavian human leucocyte antigen ancestral haplotype 62.1 as prognostic factor in patients with advanced malignant melanoma.

Helgadottir H, Andersson E, Villabona L, Kanter L, van der Zanden H, Haasnoot GW, Seliger B, Bergfeldt K, Hansson J, Ragnarsson-Olding B, Kiessling R, Masucci GV.

Cancer Immunol Immunother. 2009 Oct;58(10):1599-608. doi: 10.1007/s00262-009-0669-8. Epub 2009 Feb 13.

PMID:
19214504
20.

Quantitative assessment of the subepithelial collagen band does not increase the accuracy of diagnosis of collagenous colitis.

Rubio CA, Orrego A, Höög A, Porwitz A, Petersson F, Elmberger G, Glaessgen A, Eriksson E, Kanter L, Jaremko G, Egevad L, Laforga J, Liljefors M, Löfdahl B, Norman P, Larsson O, Wanat R, Wejde J, Zickert P, Björk J, Caini S, Palli D, Nesi G.

Am J Clin Pathol. 2008 Sep;130(3):375-81. doi: 10.1309/K7MH8UCK3MR7Q77L.

PMID:
18701410
21.

Ciclesonide improves health-related quality of life in adults and adolescents with mild-to-moderate persistent asthma.

Nathan RA, Kanter L, Ostrom NK.

Allergy Asthma Proc. 2008 Sep-Oct;29(5):521-7. doi: 10.2500/aap.2008.29.3146. Epub 2008 Aug 4.

PMID:
18684342
22.

Tumor expression of S100A6 correlates with survival of patients with stage I non-small-cell lung cancer.

De Petris L, Orre LM, Kanter L, Pernemalm M, Koyi H, Lewensohn R, Lehtiö J.

Lung Cancer. 2009 Mar;63(3):410-7. doi: 10.1016/j.lungcan.2008.06.003. Epub 2008 Jul 11.

PMID:
18620780
23.

Proteomic data analysis workflow for discovery of candidate biomarker peaks predictive of clinical outcome for patients with acute myeloid leukemia.

Forshed J, Pernemalm M, Tan CS, Lindberg M, Kanter L, Pawitan Y, Lewensohn R, Stenke L, Lehtiö J.

J Proteome Res. 2008 Jun;7(6):2332-41. doi: 10.1021/pr070482e. Epub 2008 May 2.

PMID:
18452325
24.

Safety needles.

Kanter LJ, Siegel CJ.

Ann Allergy Asthma Immunol. 2008 Apr;100(4):401; author reply 401-2. doi: 10.1016/S1081-1206(10)60609-6. No abstract available.

PMID:
18450132
25.

Analysis of HLA class I-II haplotype frequency and segregation in a cohort of patients with advanced stage ovarian cancer.

Gamzatova Z, Villabona L, van der Zanden H, Haasnoot GW, Andersson E, Kiessling R, Seliger B, Kanter L, Dalianis T, Bergfeldt K, Masucci GV.

Tissue Antigens. 2007 Sep;70(3):205-13.

PMID:
17661908
26.

Comparison of three approaches for inhibiting insulin-like growth factor I receptor and their effects on NSCLC cell lines in vitro.

Cosaceanu D, Carapancea M, Alexandru O, Budiu R, Martinsson HS, Starborg M, Vrabete M, Kanter L, Lewensohn R, Dricu A.

Growth Factors. 2007 Feb;25(1):1-8.

PMID:
17454144
27.

Reliability of the reported size of removed colorectal polyps.

Rubio CA, Grimelius L, Lindholm J, Hamberg H, Porwit A, Elmberger G, Höög A, Kanter L, Eriksson E, Stemme S, Orrego A, Saft L, Petersson F, De La Torre M, Ekström C, Astrom K, Rundgren A, Djokic M, Chandanos E, Lenander C, Machado M, Nilsson P, Mattsson L.

Anticancer Res. 2006 Nov-Dec;26(6C):4895-9.

28.

Accidental needle stick prevention: an important, costly, unsafe policy revisited.

Kanter L.

Ann Allergy Asthma Immunol. 2006 Jul;97(1):7-9. No abstract available.

PMID:
16892775
29.

Expression of DNA damage response proteins and complete remission after radiotherapy of stage IB-IIA of cervical cancer.

Beskow C, Kanter L, Holgersson A, Nilsson B, Frankendal B, Avall-Lundqvist E, Lewensohn R.

Br J Cancer. 2006 Jun 5;94(11):1683-9.

30.

Modulation of response to radiation of human lung cancer cells following insulin-like growth factor 1 receptor inactivation.

Cosaceanu D, Carapancea M, Castro J, Ekedahl J, Kanter L, Lewensohn R, Dricu A.

Cancer Lett. 2005 May 26;222(2):173-81. Epub 2004 Nov 11.

PMID:
15863266
31.

Expression of DNA-PKcs and Ku86, but not Ku70, differs between lymphoid malignancies.

Holgersson A, Erdal H, Nilsson A, Lewensohn R, Kanter L.

Exp Mol Pathol. 2004 Aug;77(1):1-6. Erratum in: Exp Mol Pathol. 2005 Aug;79(1):86. Erdal, Hamdiye [added].

PMID:
15215044
32.

NRAS and BRAF mutations arise early during melanoma pathogenesis and are preserved throughout tumor progression.

Omholt K, Platz A, Kanter L, Ringborg U, Hansson J.

Clin Cancer Res. 2003 Dec 15;9(17):6483-8.

33.

Frequency of UV-inducible NRAS mutations in melanomas of patients with germline CDKN2A mutations.

Eskandarpour M, Hashemi J, Kanter L, Ringborg U, Platz A, Hansson J.

J Natl Cancer Inst. 2003 Jun 4;95(11):790-8.

PMID:
12783933
34.

Needle sticks and adverse outcomes in office-based allergy practices.

Kanter LJ, Siegel C.

Ann Allergy Asthma Immunol. 2003 Apr;90(4):389-92.

PMID:
12722959
35.
36.

Impact of respiratory symptoms on health-related quality of life and medical resource utilization of patients treated by allergy specialists and primary care providers.

Kanter LJ, Siegel CJ, Snyder CF, Pelletier EM, Buchner DA, Goss TF.

Ann Allergy Asthma Immunol. 2002 Aug;89(2):139-47.

PMID:
12197569
37.

Biomarkers for local recurrence after breast-conservation--a nested case-control study.

Dalberg K, Eriksson E, Kanter L, Sandelin K, Liedberg A, Auer G, Thorstensson S, Fredriksson I, Johansson U, Rutqvist LE.

Breast Cancer Res Treat. 1999 Oct;57(3):245-59. No abstract available.

PMID:
10617301
39.

Reverse transcriptase polymerase chain reaction on fine needle aspirates for rapid detection of translocations in synovial sarcoma.

Nilsson G, Wang M, Wejde J, Kanter L, Karlén J, Tani E, Kreicbergs A, Larsson O.

Acta Cytol. 1998 Nov-Dec;42(6):1317-24.

PMID:
9850636
40.

Prevalence of sensitization to aeroallergens in California patients with respiratory allergy. Allergy Skin Test Project Team.

Galant S, Berger W, Gillman S, Goldsobel A, Incaudo G, Kanter L, Machtinger S, McLean A, Prenner B, Sokol W, Spector S, Welch M, Ziering W.

Ann Allergy Asthma Immunol. 1998 Sep;81(3):203-10.

PMID:
9759795
41.

Inhaled corticosteroids for asthma therapy.

Kanter L.

West J Med. 1997 Nov;167(5):348-9. No abstract available.

42.

Jump distance of dance landings influencing internal joint forces: I. Axial forces.

Simpson KJ, Kanter L.

Med Sci Sports Exerc. 1997 Jul;29(7):916-27.

PMID:
9243491
43.

A comparison of drug delivery from a metered-dose inhaler plus an inspiratory flow control device with a metered-dose inhaler plus a spacer device.

Kanner RE, Kanter LJ, Dwork P.

J Allergy Clin Immunol. 1997 Jun;99(6 Pt 1):853-4. No abstract available. Erratum in: J Allergy Clin Immunol 1998 Mar;101(3):305.

PMID:
9215257
44.

Paneth cell-rich flat adenoma of the rectum: report of a case.

Rubio CA, Kanter L, Björk J, Poppen B, Bry L.

Jpn J Cancer Res. 1996 Jan;87(1):109-12.

45.

Domestic violence against women.

Herbert B, Kanter LH.

JAMA. 1995 Nov 15;274(19):1508. No abstract available.

PMID:
7474213
46.
47.

Diffuse idiopathic skeletal hyperostosis. A case report.

Kanter LB, Black JR.

J Am Podiatr Med Assoc. 1988 May;78(5):233-7. Review. No abstract available.

PMID:
3290434
48.

[Systemic teleangiomatosis with secondary changes in the hematopoiesis].

Soboleva SS, Derbeneva LI, Glasko EN, Poliakova AS, Kanter LF.

Sov Med. 1978 Aug;(8):118-21. Russian. No abstract available.

PMID:
705440
49.

Left ventricular wall movement in heart failure.

Carson P, Kanter L.

Br Med J. 1971 Oct 9;4(5779):77-9.

50.

[Thrombohemorrhagic syndrome during resection of the lung in patients with tuberculosis].

Kanter LF.

Grudn Khir. 1967 Mar-Apr;9(2):60-5. Russian. No abstract available.

PMID:
5603414

Supplemental Content

Loading ...
Support Center